Search Results 1801-1810 of 18764 for Activation

  1. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    Activated B-cell type. High-grade B-cell lymphoma (HGBCL), NOS; High grade B-cell lymphoma with MYC and BCL2 translocation; Primary mediastinal (thymic) large ...

  2. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    Increased Plasma Levels of Human Neutrophil Peptides and Complement Activation Markers in Patients With Acquired Thrombotic Thrombocytopenic Purpura. Am J ...

  3. Clinical trials - Oncology (Medical)

    ... activation and exhaustion. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy.

  4. Clinical trials - Oncology (Medical)

    ... activation and exhaustion. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy.

  5. Clinical trials - Oncology (Medical)

    ... activation and exhaustion. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy.

  6. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

    * Participants must not have a history of macrophage activation syndrome (MAS) or hemophagocytic lymphohistiocytosis (HLH) * Participants with known history ...

  7. Publications - Stacey A. Rizza, M.D. - Mayo Clinic

    Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. J Acquir Immune Defic Syndr. 2008 Jun 1; 48 (2):149 ...

  8. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

    International normalized ratio (INR)/prothrombin time (PT) and activated partial thromboplastin time (aPTT) =< 1.5 x ULN (obtained =< 15 days prior to ...

  9. Publications - Brian A. Neff, M.D. - Mayo Clinic

    An activating germline IDH1 variant associated with a tumor entity characterized by unilateral and bilateral chondrosarcoma of the mastoid. HGG Adv. 2020 ...

  10. Coronary Artery Disease Clinical Trials - Mayo Clinic Research

    ... activate clopidogrel, and therefore may have a lowered response to clopidogrel. It is thought that perhaps people who have a coronary stent procedure may ...